Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KEAP1 | Q14145 | 1/20 | 0.68 |
| ▸ | NMUR2 | Q9GZQ4 | 5/20 | 0.64 |
| ▸ | NMUR1 | Q9HB89 | 5/20 | 0.64 |
| ▸ | NPY2R | P49146 | 7/20 | 0.62 |
| ▸ | NPY4R | P50391 | 7/20 | 0.62 |
| ▸ | NPY5R | Q15761 | 7/20 | 0.62 |
| ▸ | NPY1R | P25929 | 5/20 | 0.62 |
| ▸ | TFPI | P10646 | 2/20 | 0.61 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.61 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.60 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31230205 | 0.91 | NPY2R (0.63) | KEAP1NPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL30495778 | 0.90 | NPY2R (0.69) | KEAP1NMUR2NMUR1NPY2RNPY4R | |
| SCHEMBL30423064 | 0.90 | KEAP1 (0.69) | KEAP1NMUR2NMUR1NPY2RNPY4R | |
| SCHEMBL30712954 | 0.90 | NMUR2 (0.66) | KEAP1NMUR2NMUR1NPY2RNPY4R | |
| SCHEMBL31295738 | 0.89 | TFPI (0.64) | KEAP1NPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL31182662 | 0.89 | NPY2R (0.68) | KEAP1NMUR2NMUR1NPY2RNPY4R | |
| SCHEMBL29463778 | 0.89 | NPY2R (0.61) | KEAP1NMUR2NMUR1NPY2RNPY4R | |
| SCHEMBL29463786 | 0.89 | NPY2R (0.61) | KEAP1NMUR2NMUR1NPY2RNPY4R | |
| SCHEMBL30648456 | 0.89 | OPRM1 (0.63) | KEAP1NMUR2NMUR1NPY2RNPY4R | |
| SCHEMBL31474428 | 0.89 | RAMP3 (0.67) | KEAP1NMUR2NMUR1NPY2RNPY4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE50618-E1 | Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same | PHARMAIN CORPORATION (US) | 2025-10-07 | — | — | US | disclosed |